A Comparison of Two Operation Methods Revealed the Risk Factors and the Necessity of LN-prRLN Dissection in Papillary Thyroid Carcinoma: A Retrospective Cohort Study in FUSCC
Table 3
Univariate analysis of factors associated with LN-prRLN metastasis.
Variables
LN-prRLNM+
LN-prRLNM−
OR
value
(N = 129)
(N = 249)
Age
42.57 ± 10.90
43.41 ± 11.15
0.99 (0.97–1.01)
0.481
Sex (female vs. male)
85 (65.89%)/44 (34.11%)
206 (82.73%)/43 (17.27%)
0.40 (0.25–0.66)
≤0.001
Multifocality (yes vs. No)
49 (37.98%)/80 (62.02%)
80 (32.13%)/169 (67.87%)
1.29 (0.83–2.02)
0.255
Size (mm)
13.9 ± 9.1
9.6 ± 6.3
2.14 (1.55–2.95)
≤0.001
Extrathyroidal extension (yes vs. No)
21 (16.28%)/108 (83.72%)
15 (6.02%)/234 (93.98%)
3.03 (1.51–6.11)
0.002
Co-HT (yes vs. No)
36 (27.91%)/93 (72.09%)
104 (41.77%)/145 (58.23%)
0.54 (0.34–0.85)
0.009
Co-nodular goiter (yes vs. No)
15 (11.63%)/114 (88.37%)
43 (17.27%)/206 (82.73%)
0.63 (0.34–1.18)
0.152
Central LNM
cLNMa (yes vs. No)
107 (82.95%)/22 (17.05%)
103 (41.37%)/146 (58.63%)
6.89 (4.08–11.64)
≤0.001
cLNManumber
3 (0–29)
0 (0–9)
1.56 (1.39–1.75)
≤0.001
cLNMa size
0.81 ± 0.57
0.77 ± 0.51
1.14 (0.67–1.95)
0.630
Lateral LNM (yes vs. No)
53 (41.09%)/76 (58.91%)
35 (14.06%)/214 (85.94%)
4.26 (2.58–7.04)
≤0.001
Co-HT: concurrent Hashimoto’s thyroiditis; Conodular goiter: concomitant with nodular goiter; cLNMa: central lymph nodes anterior to the right recurrent laryngeal nerve.
